Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
TrivarX Limited ( (AU:TRI) ) just unveiled an update.
TrivarX Limited has announced the activation of a clinical trial at the West Los Angeles VA Medical Center, aimed at screening veterans for current major depressive episodes using its single-channel ECG algorithm. This trial, conducted in collaboration with the Greater Los Angeles Veterans Research and Education Foundation and the Veterans Affairs Greater Los Angeles Healthcare System, is expected to last 12 weeks and involves up to 30 participants. The trial’s success could open significant commercialization opportunities for TrivarX’s technology, enhancing its industry positioning and potential market reach.
More about TrivarX Limited
TrivarX Limited is a mental health technology company that focuses on the early detection and screening of mental health conditions using objective measures. Founded in Australia, the company operates offices in Perth and Minneapolis and is listed on the Australian Securities Exchange and the OTCQB Venture Market.
Average Trading Volume: 1,130,955
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$6.48M
For detailed information about TRI stock, go to TipRanks’ Stock Analysis page.